Roche CEO Severin Schwan Questions the Ethics of Certain Companies Making COVID-19 Antibody Tests and Calls Some of These Clinical Laboratory Tests a ‘Disaster’

May 27, 2020 | Laboratory News, Laboratory Operations, Laboratory Pathology

Schwan’s concerns about inaccurate or unreliable COVID-19 serology tests were supported when the FDA issued more restrictive rules for these medical laboratory tests on May 4 Last month, Roche Group CEO Severin Schwan characterized some COVID-19 antibody tests as a “disaster” and questioned the ethics of some manufacturers of these tests. During a conference call with investors about the company’s first-quarter results, Schwan said of the recently-launched COVID-19 antibody assays, “These...

Roche Diagnostics to Invest a Whopping $300 Million in Indianapolis to Support Expansion of its Clinical Lab Testing Business

Aug 20, 2012 | Laboratory Hiring & Human Resources, Laboratory News, Laboratory Pathology

Roche is refocusing its resources as it works to rebalance its businesses in pharmaceuticals and clinical laboratory testing Roche Diagnostics is pumping $300 million into its North American headquarters in Indianapolis. At the same time, the Roche research and development campus in Nutley, New Jersey will be closed. Collectively both actions are a sign of the company’s confidence in the growth prospects for clinical laboratory testing, molecular diagnostics, and genetic testing. Many...
;